Clinical Trials Browser

Phase 2/3 × Carcinoma, Basal Cell × Dermatologic × Clear all

NCT03070691 2017-05-05

Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Phase 2/3 Withdrawn

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT02029352 2016-05-18

Topical Green Tea Ointment in Treatment of Superficial Skin Cancer

Phase 2/3 Completed

Carcinoma, Basal Cell

NCT01260987 2015-07-30

Fractional CO2 Laser Assisted Photodynamic Therapy

Phase 2/3 Completed

Carcinoma, Basal Cell, Keratosis, Actinic